Gene · 685
Papers1,437
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,437
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in Polymeric Colloids for Cancer Treatment. | Polymers (Basel) | 2022 | 36559812 | PubTator, text mining | PubMed |
| The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD. | Life (Basel) | 2022 | 36556437 | PubTator, text mining | PubMed |
| HER3 Alterations in Cancer and Potential Clinical Implications. | Cancers (Basel) | 2022 | 36551663 | PubTator, text mining | PubMed |
| Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. | Biomolecules | 2022 | 36551308 | PubTator, text mining | PubMed |
| Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods. | Sci Rep | 2022 | 36543921 | PubTator, text mining | PubMed |
| Decreased Expression of EZH2 in Granulosa Cells Contributes to Endometriosis-Associated Infertility by Targeting IL-1R2. | Endocrinology | 2022 | 36524678 | PubTator, text mining | PubMed |
| Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells. | Front Immunol | 2022 | 36505413 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Immunomodulatory Effect of Spore-Displayed p75 on Human Intestinal Epithelial Caco-2 Cells. | Int J Mol Sci | 2022 | 36498846 | PubTator, text mining | PubMed |
| Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma? | Cancers (Basel) | 2022 | 36497413 | PubTator, text mining | PubMed |
| Targeting the EGF receptor family in non-small cell lung cancer-increased complexity and future perspectives. | Cancer Biol Med | 2022 | 36476337 | PubTator, text mining | PubMed |
| Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment. | Sci Rep | 2022 | 36473885 | PubTator, text mining | PubMed |
| A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineering. | Mol Ther Oncolytics | 2022 | 36458200 | PubTator, text mining | PubMed |
| Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma. | Front Oncol | 2022 | 36439487 | PubTator, text mining | PubMed |
| The integration of large-scale public data and network analysis uncovers molecular characteristics of psoriasis. | Hum Genomics | 2022 | 36437479 | PubTator, text mining | PubMed |
| HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the Occurrence of Bone Metabolic Diseases. | Cells | 2022 | 36428981 | PubTator, text mining | PubMed |
| Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers. | Diagnostics (Basel) | 2022 | 36428847 | PubTator, text mining | PubMed |
| Preliminary identification of pathogenic variants in an Afro-Colombian Raizal family with risk factors for glaucoma. | Colomb Med (Cali) | 2022 | 36415692 | PubTator, text mining | PubMed |
| Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients. | Sci Rep | 2022 | 36385130 | PubTator, text mining | PubMed |
| From 2D to 3D Co-Culture Systems: A Review of Co-Culture Models to Study the Neural Cells Interaction. | Int J Mol Sci | 2022 | 36361902 | PubTator, text mining | PubMed |
| miRNAs as Biomarkers in Diabetes: Moving towards Precision Medicine. | Int J Mol Sci | 2022 | 36361633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/685/papers?page=8